Photo of J.D. Vance
R United States Senate · Ohio

Sen. J.D. Vance

Compare
Total votes
218
all sessions
Attendance
82%
40 missed
Higher than 92% of chamber peers
With party
70%
of cast votes
Higher than 98% of chamber peers
Bipartisan score
16%
some cross-party votes
Among the lowest in the chamber
Sponsored
312
bills & resolutions
Among the lowest in the chamber
Committees
0
assignments
312 bills and resolutions

Sponsored bills

Total
312
Primary
36
Co-sponsor
276
This page
312
matching current filters
Primary S 3638
In committee · United States Senate · Lead sponsor
Dependent Controlled Substance Transparency Act

Maddy summaryThis bill requires health plans and insurers to share information about controlled substances prescribed to adult children (who are dependents on the policyholder's plan) with the policyholder upon request. It directly affects parents or guardians enrolled in health plans covering adult dependent children. The key provision mandates disclosure of controlled substance prescriptions, but excludes medication-assisted treatment for substance use disorders. The law does not change existing privacy rules for other health information, only creating this specific exception for adult dependents' controlled substance prescriptions.

In committee Jan 23, 2024 0 co-sponsors
Co-sponsor SRES 523
Passed · United States Senate · Co-sponsor
A resolution honoring the life and legacy of the late Senator Herb Kohl.

Maddy summarySRES 523 is a Senate resolution honoring the late Senator Herb Kohl of Wisconsin. The resolution expresses the Senate's sorrow at his death, directs the Secretary of the Senate to communicate it to the House of Representatives and send a copy to his family, and instructs the Senate to adjourn as a mark of respect. This procedural resolution does not create new laws or affect policy, but formally commemorates Kohl's service and legacy. It was introduced by a bipartisan group of Senators and passed unanimously on January 11, 2024.

Passed Jan 18, 2024 1 co-sponsor
Co-sponsor S 3627
In committee · United States Senate · Co-sponsor
Distribution Transformer Efficiency and Supply Chain Reliability Act of 2024

Maddy summaryS 3627, the Distribution Transformer Efficiency and Supply Chain Reliability Act of 2024, prevents federal rules from requiring distribution transformers to meet efficiency levels stricter than "trial standard level 2" for liquid-immersed and dry-type transformers. It directly affects manufacturers of these transformers by limiting future efficiency standards. The key provision delays any finalized rule for "trial standard level 1 or 2" efficiency from taking effect for 10 years after finalization. This bill aims to provide stability for the supply chain by slowing the implementation of stricter efficiency requirements.

In committee Jan 18, 2024 1 co-sponsor
Co-sponsor S 3604
In committee · United States Senate · Co-sponsor
Safeguarding Charity Act

Maddy summaryS 3604, the Safeguarding Charity Act, clarifies that tax exemptions under IRS Section 501(c) or 401(a) do not count as "Federal financial assistance" for regulatory purposes. The bill amends U.S. Code to explicitly exclude tax-exempt status from definitions of federal assistance in all federal laws, rules, or regulations. This directly affects tax-exempt charities and nonprofits that rely on IRS 501(c) status, ensuring their tax exemptions are not treated as government funding when applying federal programs or requirements.

In committee Jan 17, 2024 1 co-sponsor
Co-sponsor S 3600
In committee · United States Senate · Co-sponsor
Teamwork for Employees and Managers Act of 2024

Maddy summaryThis bill creates "employee involvement organizations" (EIOs), allowing employers and employees to form voluntary groups to discuss workplace issues like safety, compensation, and benefits - without replacing union representation. It explicitly prohibits EIOs from negotiating contracts, seeking exclusive bargaining rights, or blocking employees from joining unions. For large employers (over $1 billion in revenue or 3,000+ employees), the bill requires formal certification of EIOs, limits dissolution to "cause" after 5 years, and mandates employee-elected representatives with specific eligibility rules. The law preserves existing union rights under the National Labor Relations Act and clarifies that employers won’t face penalties if EIOs fail due to employee fault.

In committee Jan 17, 2024 1 co-sponsor
Co-sponsor S 3578
In committee · United States Senate · Co-sponsor
Protect Medicaid Act

Maddy summaryThis bill prohibits federal Medicaid funding from covering administrative costs for health benefits provided to unauthorized immigrants (noncitizens ineligible due to immigration status). It directly affects states that currently provide Medicaid benefits to such individuals by blocking federal reimbursement for related administrative expenses. Key provisions include amending federal law to create a specific funding restriction and requiring a detailed Inspector General report on state compliance, cost separation methods, and financing approaches for these programs. The report must also analyze whether providing covered drugs to unauthorized immigrants affects drug pricing under Medicaid and 340B programs. The bill focuses on altering funding rules and mandating oversight, not on changing eligibility for benefits.

In committee Jan 11, 2024 1 co-sponsor
Co-sponsor S 3587
In committee · United States Senate · Co-sponsor
Mandatory Removal Proceedings Act

Maddy summaryThe Mandatory Removal Proceedings Act (S 3587) requires the Secretary of Homeland Security to immediately start removal proceedings for non-citizens whose visas are revoked due to security concerns. It removes the previous discretion of the Secretary to decide whether to proceed, mandating automatic removal when a visa revocation occurs under specific security grounds outlined in immigration law. This policy directly affects foreign nationals with visas revoked on security-related grounds, such as those posing threats to national security. The bill changes the procedural step after visa revocation without altering the grounds for revocation itself.

In committee Jan 11, 2024 1 co-sponsor
Co-sponsor S 3588
In committee · United States Senate · Co-sponsor
Constitutional Election Integrity Act

Maddy summaryS 3588, the Constitutional Election Integrity Act, prohibits federal funding for election administration in states that block presidential candidates from appearing on ballots using Section 3 of the Fourteenth Amendment (which disqualifies individuals who engaged in insurrection). It directly affects states administering federal elections by cutting off federal funds if they restrict ballot access for candidates under this constitutional provision. The bill shifts jurisdiction for disputes over presidential ballot eligibility under Section 3 to federal courts, requiring three-judge panels to handle cases and send findings to the Supreme Court for expedited review. It also explicitly bars state courts and officials from deciding such disputes, centralizing legal challenges in federal courts.

In committee Jan 11, 2024 1 co-sponsor
Co-sponsor S 2824
In committee · United States Senate · Co-sponsor
Secure the Border Act of 2023

Maddy summary# Summary of "Secure the Border Act of 2023" (Employment Eligibility Verification Provisions) This legislation (primarily Sections 801-816) fundamentally reforms the U.S. employment eligibility verification system by replacing the current E-Verify program with a new, mandatory verification system for employers. ## Key Provisions: 1. **Mandatory Verification System**: Requires all employers to verify the work authorization of new hires through a new verification system established under Section 274A(d). 2. **Phased Implementation Timeline**: - Large employers (10,000+ employees): 6 months after enactment - Medium employers (500-10,000 employees): 12 months after enactment - Small employers (20-500 employees): 18 months after enactment - Very small employers (<20 employees): 24 months after enactment - Agricultural workers: 36 months after enactment 3. **Verification Process**: - Requires examination of specific documents to verify identity and work authorization - Establishes a verification system with confirmation or tentative nonconfirmation within 3 business days - Requires secondary verification process for tentative nonconfirmations 4. **Penalties for Non-Compliance**: - Civil penalties ranging from $2,500 to $25,000 per violation - Criminal penalties for pattern or practice violations ($5,000 per unauthorized alien) - Potential debarment from federal contracts for repeat violators 5. **Fraud Prevention Measures**: - Blocks social security account numbers subject to unusual multiple use - Allows suspension of compromised social security numbers - Protects children's identities from being used for employment verification 6. **Agricultural Workforce Provisions**: - Extended timeline for agricultural workers (36 months) - Specific definitions of agricultural labor - Study on agricultural workforce composition and recommendations 7. **Good Faith Defense**: - Allows employers to avoid penalties if they can demonstrate good faith compliance - Requires reasonable security measures for identity verification This legislation represents a significant expansion of employer verification requirements with substantial penalties for non-compliance, designed to strengthen enforcement against unauthorized employment while establishing a more comprehensive verification system. The phased approach aims to give employers time to adjust to the new requirements based on business size.

In committee Jan 11, 2024 1 co-sponsor
Co-sponsor S 993
In committee · United States Senate · Co-sponsor
Combating Illicit Xylazine Act

Maddy summaryS 993, the Combating Illicit Xylazine Act, makes the illicit distribution and use of xylazine illegal under federal drug laws. The bill defines xylazine broadly (including multiple chemical variants) and prohibits all human use or non-lici distribution, while allowing only veterinary and pharmaceutical uses approved under existing regulations. It requires the DEA and FDA to report to Congress within a year on xylazine's spread and impacts, with a follow-up report four years later. This directly affects drug traffickers and distributors adding xylazine to illicit drugs like fentanyl, aiming to address a public health threat linked to severe health consequences including necrosis.

In committee Jan 11, 2024 1 co-sponsor
Showing 91 to 100 of 312 bills
Previous 1 … 9 10 11 … 32 Next